CooperVision produces hand sanitizer at manufacturing sites

Article

Initiative helps eye care and local communities address COVID-19

In response to the ongoing COVID-19 pandemic, CooperVision converted two of its manufacturing facilities into hand sanitizer production sites. One manufacturing location is in Hampshire, United Kingdom, the other is in Juana Diaz, Puerto Rico.

Benefits are two-fold: a portion of the sanitizer that is being produced stocks internal supplies for employee hygiene needs. This consistent, internal supply ensures commercial stocks are freed for consumer use elsewhere, according to the company. Additional reserves are being donated to community organizations and customers.

Related: CooperVision reveals virtual exhibit booth

Before conversion, the UK and Juana Diaz sites were manufacturing a range of contact lenses, including Biofinity and MyDay. Laboratory and operating procedure re-designs were issued in order to meet material handling retirements. The company was able to produce bottles of hand sanitizer in volume—safely, efficiently and in line with World Health Organization (WHO) guidelines—within 3 weeks.


Community recipients include areas of the National Health Service, schools, community facilities, care homes, and charities. In the US, the company has distributed complimentary bottles to customers as well.

Related: Allergan receives FDA complete response letter for wet AMD therapy

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Jessilin Quint, OD, MBA, FAAO, outlines her AOA's Optometry's Meeting 2025 presentation on nutrition and its impact on ocular health.
Carolyn Majcher, OD, FAAO, detailed a talk she gave alongside Mary Beth Yackey, OD, at Optometry's Meeting 2025.
Shelby Brogdon, OD, details opportunities for practices to answer the patient's concerns from the chair before they hit the internet for their contact lens needs.
Christi Closson, OD, FAAO, shares her excitement for the new Acuvue Oasys MAX 1-Day multifocal for astigmatism
Karen R. Hoffman, OD, shares how customizable scleral lenses can transform vision for patients with complex corneas, achieving 20/20 outcomes and enhanced comfort.
Janna Pham, OD, shares key takeaways from a corneal tomography session she presented alongside Travis Pfeifer, OD; and Matthew McGee, OD.
Jacob Lang, OD, FAAO, details early symptom relief demonstrated in as early as day 1 during AOA's Optometry's Meeting 2025.
When Langis Michaud, OD, MSc, FAAO, FSLS, FBCLA, FEAOO, began fitting scleral lenses 20 years ago, there was limited knowledge about conjunctival characteristics, scleral shape, and lens behavior.
Ioussifova details what sets Johnson & Johnson's new lens apart from the rest, which was launched at the American Optometric Association's Optometry's Meeting 2025.
Alongside Rachel Steele, OD, Rafieetary outlines what to look for in blurred disc margins and the importance of acting fast and sending patients to the ED when needed.
© 2025 MJH Life Sciences

All rights reserved.